Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 51655-427

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 51655-427). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 427 53 Master Bottle Label Approval Rev A 09 20)

Label (51655 427 53 Master Bottle Label Approval   Rev A 09 20)
NDC 51655-427-53 is a medication that contains Cyclobenzaprine Hydrochloride tablets. Unfortunately, due to the mixture of incorrect characters and words, the remaining sentence is not intelligible or useful.*
FDA Label Image

Image (Cyclobenzaprine HCl Tabs Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.